Perflenapent emulsion. Ultrasound contrast media

Drugs of the Future

Volumn 22, Issue 4, 1997, Pages 378-385

  Worah, Dilip M ^a   Kessler, Dean R ^a   Meuter, Adrienne R ^a   Huang, Marissa G ^a   Correas, Jean Michel ^b   Quay, Steven C ^a  

^a Sonus Pharmaceuticals   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUNEX; ECHO CONTRAST MEDIUM; PERFLUOROPENTANE; STABILIZING AGENT; SURFACTANT;

ARTICLE; BLOOD VESSEL FUNCTION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DRUG CLEARANCE; DRUG DESIGN; DRUG FORMULATION; DRUG SAFETY; DRUG UPTAKE; ECHOGRAPHY; EMULSION; HEART FUNCTION; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MUTAGEN TESTING; NONHUMAN; TOXICITY TESTING;

EID: 0030769562     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Balen, F., Allen, C., Lees, W. Review. Ultrasound contrast agents. Clin Radiol 1994, 49: 77-82.
2. Correas, J.-M., Quay, S. EchoGen® emulsion: A new ultrasound contrast agent based on phase shift colloids. Clin Radiol 1996, 51(Suppl. 1): 11-4.
3. Goldberg, B., Liu, J., Forsberg, F. Ultrasound contrast agents: A review. Ultrasound Med Biol 1994, 20: 319-33.
4. Epstein, P., Plesset, M. On the stability of gas bubbles in liquid-gas solutions. J Chem Phys 1950, 18: 1505-9.
5. Trevino, L., Sole-Violan, L., Daumur, P. et al. New J Chem 1993, 17: 275.
6. deJong, N. Acoustic properties of ultrasound contrast agents. Doctoral Thesis, Erasmus University, Rotterdam 1993, 27.
7. Quay, S. (Sonus Pharm., Inc.). Gaseous ultrasound contrast media. US 5409688.
8. Quay, S. (Sonus Pharm., Inc.). Methods for selecting and using gases as ultrasound contrast media. US 5393524.
9. Quay, S. (Sonus Pharm., Inc.). Persistence of gaseous bubbles as ultrasound contrast media. US 5573751.
10. Quay. S. (Sonus Pharm. Inc.). Phase shift colloids as ultrasound contrast agents. US 5558855.
11. Quay, S. (Sonus Pharm., Inc.). Ultrasound contrast media comprising perfluoropentane and perfluorohexane gas. US 5558854.
12. Quay, S. (Sonus Pharm., Inc.). Methods for using persistent gases as ultrasound contrast media. US 5558094.
13. Quay, S. (Sonus Pharm., Inc.). Method for preparing storage stable colloids. US 5595723.
14. Grayburn, P., Erickson, J., Escobar, J., Womack, L., Velasco, C. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemia. J Amer Coll Cardiol 1995, 26: 1340-7.
15. Ge, S., Geraud, G., Shiota, T. et al. Microcirculatory flow dynamics during peripheral intravenous injection of EchoGen: Microscopic visualization of mesenteric microcirculatory flow with simultaneous transthoracic echo imaging in cats. J Amer Coll Cardiol 1995, 25: 227A.
16. Forsberg, F., Liu, J., Merton, D., Rawool, N., Goldberg, B. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 1995, 14: 949-57.
17. Wollen, H. Human inhalation pharmacokinetics of chlorofluoromethane (HCFC22). Occup Environ Health 1992, 94: 383-7.